Simbryo Technologies, Inc.
PrivateLast Round
Seed
Nov 1, 2025
Total Funding Raised
$10,000
Company Overview
Simbryo Technologies, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Seed round in November 2025.
Simbryo Technologies, Inc. is a biotechnology company that develops precision diagnostic tools using patient-derived endometrial organoids to assess endometrial fertility and improve IVF success rates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simbryo Technologies, Inc. Comparables
Compare Simbryo Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inti Labs | 89% | |
| Cicero Diagnostics, Inc. | 76% | |
| Vitrolife AB | 76% |
For institutional investors. Book with your work email.
Simbryo Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2025 | ||||
| Seed Round | Sep 26, 2025 | ||||
| Grant | Sep 17, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Simbryo Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keyhorse Capital | Seed |
| Cintrifuse Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
Seed round raised with participation from Keyhorse Capital and Cintrifuse Capital.
- Sep 26, 2025
$5.25M raised in Seed Round.
For institutional investors. Book with your work email.
Simbryo Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Simbryo Technologies, Inc.'s valuation, stock price, and market status.
Is Simbryo Technologies, Inc. a public or private company?
Simbryo Technologies, Inc. is a private company.
What is the current stock price of Simbryo Technologies, Inc.?
Simbryo Technologies, Inc. is a private company, so its shares have no public market price. Caplight tracks Simbryo Technologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Simbryo Technologies, Inc. worth (valuation)?
Valuation information for Simbryo Technologies, Inc. is not publicly available.
Can I buy Simbryo Technologies, Inc. stock?
Simbryo Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Simbryo Technologies, Inc.'s last funding round?
Simbryo Technologies, Inc.'s most recent funding round was Seed on November 1, 2025.
Who are the main investors in Simbryo Technologies, Inc.?
Key investors in Simbryo Technologies, Inc. include Keyhorse Capital, Cintrifuse Capital.
Will Simbryo Technologies, Inc. IPO soon?
No public IPO plans have been announced for Simbryo Technologies, Inc..
How can I track Simbryo Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Simbryo Technologies, Inc.'s shares on secondary markets.